What is Nektar Therapeutics's investment purchases?

Nektar Therapeutics (NKTR) reported investment purchases of $452.25M in Q1 2026.

How has Nektar Therapeutics's investment purchases changed year-over-year?

Nektar Therapeutics's investment purchases increased by 1714.0% year-over-year, from $24.93M to $452.25M.

What is the long-term trend for Nektar Therapeutics's investment purchases?

Over 4 years (2021 to 2025), Nektar Therapeutics's investment purchases has grown at a -26.2% compound annual growth rate (CAGR), from $960.69M to $285.01M.

What does investment purchases mean?

Cash spent purchasing investment securities across all categories.

Nektar Therapeutics NKTR Investment Purchases

Investment Purchases at other companies

ImmunityBio, Inc.IBRX

$139.09M+138,993%

Iovance Biotherapeutics, Inc.IOVA

$56M-42.8%

Kymera TherapeuticsKYMR

$276.27M+230%

Viridian Therapeutics, Inc.VRDN

$91.32M+28.2%

Johnson & JohnsonJNJ

$144M-42.6%

Protagonist TherapeuticsPTGX

$68.97M-67.8%

Other financials

Income statement

See full

Revenue$10.9M+3.8%

Gross profit$21.8M+2.9%

Operating income-$39.1M+12.3%

Net income-$44.9M+11.7%

EPS (diluted)-$1.82+49.7%

Balance sheet

See full

Cash & equivalents$5.7M-20.0%

Total debt$83.2M-17.1%

Total equity$576.2M+4,094%

Total assets$763.3M+198%

Cash flow

See full

Operating cash flow-$44.3M+9.7%

CapEx$18.0K+800%

Free cash flow-$44.3M+9.7%

Valuation

See full

Market cap$2.25B+1,531%

Enterprise value$2.33B+874%

P/S40.5×+38.9×

Profitability

See full

Gross margin100%+31.2pp

Operating margin-242%—

Net margin-284.2%+937pp

FCF margin-366.6%+1,421pp

Returns & leverage

See full

Return on equity-53.6%-22.6pp

Debt / equity0.1×-7.2×

Current ratio10.2×+7.0×

Where this comes from

Reported directly by Nektar Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt.

The official record: Nektar Therapeutics’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nektar Therapeutics's investment purchases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Nektar Therapeutics's investment purchases?: Nektar Therapeutics (NKTR) reported investment purchases of $452.25M in Q1 2026.
How has Nektar Therapeutics's investment purchases changed year-over-year?: Nektar Therapeutics's investment purchases increased by 1714.0% year-over-year, from $24.93M to $452.25M.
What is the long-term trend for Nektar Therapeutics's investment purchases?: Over 4 years (2021 to 2025), Nektar Therapeutics's investment purchases has grown at a -26.2% compound annual growth rate (CAGR), from $960.69M to $285.01M.
What does investment purchases mean?: Cash spent purchasing investment securities across all categories.